Literature DB >> 20588106

Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling.

Charles S Morrison1, Pai-Lien Chen, Cynthia Kwok, Barbra A Richardson, Tsungai Chipato, Roy Mugerwa, Josaphat Byamugisha, Nancy Padian, David D Celentano, Robert A Salata.   

Abstract

Hormonal contraceptives are used widely worldwide; their effect on HIV acquisition remains unresolved. We reanalyzed data from the Hormonal Contraception and HIV Study using marginal structural modeling to reduce selection bias due to time-dependent confounding. Replicating our original analysis closely, we found that depo-medroxyprogesterone acetate (DMPA) but not combined oral contraceptive (COC) was associated with increased HIV acquisition. Also, young (18-24 years) but not older women who used DMPA and COCs were at increased HIV risk.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20588106      PMCID： PMC3148067          DOI： 10.1097/QAD.0b013e32833a2537

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


  32 in total

1.  Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.

Authors:  Landon Myer; Lynette Denny; Thomas C Wright; Louise Kuhn
Journal:  Int J Epidemiol       Date:  2006-12-14       Impact factor: 7.196

2.  Hormonal contraception and the risk of HIV acquisition.

Authors:  Charles S Morrison; Barbra A Richardson; Francis Mmiro; Tsungai Chipato; David D Celentano; Joanne Luoto; Roy Mugerwa; Nancy Padian; Sungwal Rugpao; Joelle M Brown; Peter Cornelisse; Robert A Salata
Journal:  AIDS       Date:  2007-01-02       Impact factor: 4.177

3.  Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study.

Authors:  Jonathan A C Sterne; Miguel A Hernán; Bruno Ledergerber; Kate Tilling; Rainer Weber; Pedram Sendi; Martin Rickenbach; James M Robins; Matthias Egger
Journal:  Lancet       Date:  2005 Jul 30-Aug 5       Impact factor: 79.321

Review 4.  A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle.

Authors:  Charles R Wira; John V Fahey
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177

5.  Constructing inverse probability weights for marginal structural models.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2008-08-05       Impact factor: 4.897

6.  Hormonal contraceptive use modulates the local inflammatory response to bacterial vaginosis.

Authors:  T L Cherpes; J M Marrazzo; L A Cosentino; L A Meyn; P J Murray; S L Hillier
Journal:  Sex Transm Infect       Date:  2007-10-02       Impact factor: 3.519

7.  A longitudinal study of vaginal douching and bacterial vaginosis--a marginal structural modeling analysis.

Authors:  Rebecca M Brotman; Mark A Klebanoff; Tonja R Nansel; William W Andrews; Jane R Schwebke; Jun Zhang; Kai F Yu; Jonathan M Zenilman; Daniel O Scharfstein
Journal:  Am J Epidemiol       Date:  2008-05-23       Impact factor: 4.897

8.  Natural history and risk factors associated with early and established HIV type 1 infection among reproductive-age women in Malawi.

Authors:  Johnstone J Kumwenda; Bonus Makanani; Frank Taulo; Chiwawa Nkhoma; George Kafulafula; Qing Li; Newton Kumwenda; Taha E Taha
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

9.  Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women.

Authors:  Jared M Baeten; Sarah Benki; Vrasha Chohan; Ludo Lavreys; R Scott McClelland; Kishorchandra Mandaliya; Jeckoniah O Ndinya-Achola; Walter Jaoko; Julie Overbaugh
Journal:  AIDS       Date:  2007-08-20       Impact factor: 4.177

10.  Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort.

Authors:  Immo Kleinschmidt; Helen Rees; Sinead Delany; Dawn Smith; Natalya Dinat; Busi Nkala; James A McIntyre
Journal:  Contraception       Date:  2007-04-05       Impact factor: 3.375
View more
  74 in total

1.  Contraceptive Preference Among Women at Risk of HIV Acquisition in a Preparatory Screening Study for a Phase III Microbicide Trial in South Western Uganda.

Authors:  Sylvia Kusemererwa; Andrew Abaasa; Martin Onyango; Annalene M Nel; Michelle Isaacs; Gershim Asiki
Journal:  AIDS Behav       Date:  2018-07

2.  A Depot Medroxyprogesterone Acetate Dose That Models Human Use and Its Effect on Vaginal SHIV Acquisition Risk.

Authors:  Katherine Butler; Jana M Ritter; Shanon Ellis; Monica R Morris; Debra L Hanson; Janet M McNicholl; Ellen N Kersh
Journal:  J Acquir Immune Defic Syndr       Date:  2016-08-01       Impact factor: 3.731

3.  Changes in Vaginal Microbiota and Immune Mediators in HIV-1-Seronegative Kenyan Women Initiating Depot Medroxyprogesterone Acetate.

Authors:  Alison C Roxby; David N Fredricks; Katherine Odem-Davis; Kristjana Ásbjörnsdóttir; Linnet Masese; Tina L Fiedler; Stephen De Rosa; Walter Jaoko; James N Kiarie; Julie Overbaugh; R Scott McClelland
Journal:  J Acquir Immune Defic Syndr       Date:  2016-04-01       Impact factor: 3.731

4.  Hormonal contraception and area of cervical ectopy: a longitudinal assessment.

Authors:  Patricia L Bright; Abigail Norris Turner; Charles S Morrison; Emelita L Wong; Cynthia Kwok; Irina Yacobson; Rachel A Royce; Heidi O Tucker; Paul D Blumenthal
Journal:  Contraception       Date:  2011-03-23       Impact factor: 3.375

Review 5.  Clinical parameters essential to methodology and interpretation of mucosal responses.

Authors:  Brenna L Anderson; Susan Cu-Uvin
Journal:  Am J Reprod Immunol       Date:  2011-01-12       Impact factor: 3.886

6.  The contraceptive depot medroxyprogesterone acetate impairs mycobacterial control and inhibits cytokine secretion in mice infected with Mycobacterium tuberculosis.

Authors:  Léanie Kleynhans; Nelita Du Plessis; Nasiema Allie; Muazzam Jacobs; Martin Kidd; Paul D van Helden; Gerhard Walzl; Katharina Ronacher
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

Review 7.  The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?

Authors:  Muki S Shey; Nigel J Garrett; Lyle R McKinnon; Jo-Ann S Passmore
Journal:  Innate Immun       Date:  2013-11-26       Impact factor: 2.680

8.  Effect of hormonal contraception on the function of plasmacytoid dendritic cells and distribution of immune cell populations in the female reproductive tract.

Authors:  Katherine G Michel; Richard P H Huijbregts; Jonathan L Gleason; Holly E Richter; Zdenek Hel
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-15       Impact factor: 3.731

9.  Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception.

Authors:  Renee Heffron; Nelly Mugo; Edwin Were; James Kiarie; Elizabeth A Bukusi; Andrew Mujugira; Lisa M Frenkel; Deborah Donnell; Allan Ronald; Connie Celum; Jared M Baeten
Journal:  AIDS       Date:  2014-11-28       Impact factor: 4.177

10.  Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals?

Authors:  Chelsea B Polis; Sharon J Phillips; Sharon L Hillier; Sharon L Achilles
Journal:  AIDS       Date:  2016-11-13       Impact factor: 4.177
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.